ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 567,49
-0,85%
Dow Jones
40 211,72
0,00%
DAX
18 478,09
-0,66%
Brent Oil
82,975
-1,62%
Bitcoin
63 721,18
-1,74%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
20/04/202314h00PR Newswire (US)Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023NASDAQ:INSMInsmed Inc
06/04/202314h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
31/03/202322h11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
31/03/202322h10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
31/03/202314h00PR Newswire (US)Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in BronchiectasisNASDAQ:INSMInsmed Inc
17/03/202321h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
01/03/202314h00PR Newswire (US)Insmed To Present at Two March ConferencesNASDAQ:INSMInsmed Inc
23/02/202313h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
23/02/202313h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
23/02/202313h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
14/02/202322h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
14/02/202318h44Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INSMInsmed Inc
09/02/202314h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023NASDAQ:INSMInsmed Inc
07/02/202314h00PR Newswire (US)Insmed To Present at the SVB Securities Global Biopharma ConferenceNASDAQ:INSMInsmed Inc
26/01/202316h45Business WireAnalysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment ForumNASDAQ:INSMInsmed Inc
12/01/202322h17Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:INSMInsmed Inc
06/01/202314h00PR Newswire (US)Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
03/01/202314h00PR Newswire (US)Insmed To Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
08/12/202222h15TipRanksMizuho Securities Initiates a Buy Rating on Insmed (INSM)NASDAQ:INSMInsmed Inc
30/11/202214h00PR Newswire (US)Insmed To Present at the Nasdaq 47th Investor ConferenceNASDAQ:INSMInsmed Inc
01/11/202213h00PR Newswire (US)Insmed To Present at Three November ConferencesNASDAQ:INSMInsmed Inc
28/10/202212h25TipRanksInsmed (INSM) Receives a Buy from H.C. WainwrightNASDAQ:INSMInsmed Inc
27/10/202222h35TipRanksSVB Securities Sticks to Their Buy Rating for Insmed (INSM)NASDAQ:INSMInsmed Inc
27/10/202222h05PR Newswire (US)Insmed Ranks No. 1 on Science's 2022 Top Biopharma Employers ListNASDAQ:INSMInsmed Inc
27/10/202213h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
27/10/202213h30PR Newswire (US)Insmed Reports Third Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
19/10/202222h25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INSMInsmed Inc
19/10/202214h50PR Newswire (US)Insmed Announces Strategic Financings Totaling $775 MillionNASDAQ:INSMInsmed Inc
13/10/202214h00PR Newswire (US)Insmed to Host Third Quarter 2022 Financial Results Conference Call on Thursday, October 27, 2022NASDAQ:INSMInsmed Inc
06/10/202214h00PR Newswire (US)Insmed Holds Inaugural Global Day of Good - A Company-Wide Day of ServiceNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
HO
Thales
EU
DG
Vinci
EU
BN
Danone
NASDAQ
MSFT
Microsoft
EU
ML
Michelin
EU
BEL20
Bel 20
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
EU
ACA
Credit Agricole
EU
VIV
Vivendi
NYSE
DIS
Walt Disney
FTSE
UKX
FTSE 100
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés